TR201802700T4 - Sterol deriveleri ve dönüştürülmüş astrosit hücreleri içeren hastalıkların tedavi edilmesine yönelik veya malignan hemopatilerin tedavi edilmesine yönelik olarak bunların kullanımı. - Google Patents
Sterol deriveleri ve dönüştürülmüş astrosit hücreleri içeren hastalıkların tedavi edilmesine yönelik veya malignan hemopatilerin tedavi edilmesine yönelik olarak bunların kullanımı. Download PDFInfo
- Publication number
- TR201802700T4 TR201802700T4 TR2018/02700T TR201802700T TR201802700T4 TR 201802700 T4 TR201802700 T4 TR 201802700T4 TR 2018/02700 T TR2018/02700 T TR 2018/02700T TR 201802700 T TR201802700 T TR 201802700T TR 201802700 T4 TR201802700 T4 TR 201802700T4
- Authority
- TR
- Turkey
- Prior art keywords
- dimethyl
- molecule
- cells
- cyclopenta
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12305518.8A EP2662382B1 (fr) | 2012-05-10 | 2012-05-10 | Dérivés de stérol, leur procédé de préparation, les compositions pharmaceutiques les contenant et leur utilisation pour le traitement du glioblastome multiple |
| US201261656151P | 2012-06-06 | 2012-06-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201802700T4 true TR201802700T4 (tr) | 2018-03-21 |
Family
ID=46149353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2018/02700T TR201802700T4 (tr) | 2012-05-10 | 2013-05-07 | Sterol deriveleri ve dönüştürülmüş astrosit hücreleri içeren hastalıkların tedavi edilmesine yönelik veya malignan hemopatilerin tedavi edilmesine yönelik olarak bunların kullanımı. |
Country Status (23)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3013048A1 (fr) * | 2013-11-12 | 2015-05-15 | Beta Innov | Derive de sterol, son procede de preparation, composition pharmaceutique le contenant et son utilisation pour le traitement du glioblastome multiforme |
| EP3593789A1 (fr) * | 2018-07-11 | 2020-01-15 | Beta Innov | Composition contenant un dérivé de 7beta-hydroxycholestérol et un véhicule lipidique, et son utilisation dans le traitement de pathologies néoplasiques |
| KR102689231B1 (ko) * | 2021-05-18 | 2024-07-30 | 연세대학교 산학협력단 | 암의 예방, 개선 또는 치료용 조성물 |
| KR102748745B1 (ko) * | 2021-05-18 | 2025-01-03 | 연세대학교 산학협력단 | 암의 예방, 개선 또는 치료용 조성물 |
| WO2024030660A2 (en) * | 2022-08-04 | 2024-02-08 | University Of Massachusetts | Cholesterol-modified hyaluronic acids |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9602100D0 (sv) * | 1996-05-30 | 1996-05-30 | Magnus Axelson | New pharmaceuticals |
| JP2006503840A (ja) * | 2002-09-25 | 2006-02-02 | フォーブス メディ−テック インコーポレーテッド | ステロール及び／又はスタノール及び抗炎症剤の特定の種類を含有する新規構造体及び組成物、並びに、心血管疾患、その根底にある高脂血症を含む病気、及び原因又は症状の一部として炎症を有する他の障害の治療又は予防におけるそれらの使用 |
-
2012
- 2012-05-10 EP EP12305518.8A patent/EP2662382B1/fr active Active
- 2012-05-10 DK DK12305518.8T patent/DK2662382T3/en active
- 2012-05-10 ME MEP-2016-134A patent/ME02436B/me unknown
- 2012-05-10 HU HUE12305518A patent/HUE029243T2/en unknown
- 2012-05-10 RS RS20160499A patent/RS54926B1/sr unknown
- 2012-05-10 ES ES12305518.8T patent/ES2580331T3/es active Active
- 2012-05-10 PT PT123055188T patent/PT2662382T/pt unknown
- 2012-05-10 SI SI201230585A patent/SI2662382T1/sl unknown
- 2012-05-10 PL PL12305518.8T patent/PL2662382T3/pl unknown
-
2013
- 2013-05-07 LT LTEP13729470.8T patent/LT2847204T/lt unknown
- 2013-05-07 SI SI201330962T patent/SI2847204T1/en unknown
- 2013-05-07 RU RU2014149705A patent/RU2627710C2/ru active
- 2013-05-07 CN CN201380023824.4A patent/CN104302655B/zh active Active
- 2013-05-07 TR TR2018/02700T patent/TR201802700T4/tr unknown
- 2013-05-07 HR HRP20180345TT patent/HRP20180345T1/hr unknown
- 2013-05-07 CA CA2871714A patent/CA2871714C/en active Active
- 2013-05-07 JP JP2015510925A patent/JP6270823B2/ja active Active
- 2013-05-07 US US14/399,336 patent/US10800806B2/en active Active
- 2013-05-07 WO PCT/IB2013/053669 patent/WO2013168096A1/en not_active Ceased
- 2013-05-07 PT PT137294708T patent/PT2847204T/pt unknown
- 2013-05-07 ES ES13729470.8T patent/ES2662123T3/es active Active
- 2013-05-07 KR KR1020147034290A patent/KR102160316B1/ko active Active
- 2013-05-07 HU HUE13729470A patent/HUE037004T2/hu unknown
- 2013-05-07 PL PL13729470T patent/PL2847204T3/pl unknown
- 2013-05-07 IN IN9437DEN2014 patent/IN2014DN09437A/en unknown
- 2013-05-07 BR BR112014026948-3A patent/BR112014026948B1/pt active IP Right Grant
- 2013-05-07 RS RS20180237A patent/RS57065B1/sr unknown
- 2013-05-07 EP EP13729470.8A patent/EP2847204B1/en active Active
- 2013-05-07 SM SM20180147T patent/SMT201800147T1/it unknown
- 2013-05-07 DK DK13729470.8T patent/DK2847204T3/en active
-
2016
- 2016-06-07 HR HRP20160624TT patent/HRP20160624T1/hr unknown
- 2016-07-05 SM SM201600215T patent/SMT201600215B/it unknown
- 2016-07-05 CY CY20161100621T patent/CY1117723T1/el unknown
-
2018
- 2018-03-13 CY CY20181100306T patent/CY1120395T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5992019B2 (ja) | リポソームナノ粒子中で使用するための修飾薬物 | |
| TR201802700T4 (tr) | Sterol deriveleri ve dönüştürülmüş astrosit hücreleri içeren hastalıkların tedavi edilmesine yönelik veya malignan hemopatilerin tedavi edilmesine yönelik olarak bunların kullanımı. | |
| WO2023207101A1 (en) | Ionizable lipid compounds | |
| Dandash et al. | In vitro anticancer activity of new gold (III) porphyrin complexes in colon cancer cells | |
| Sun et al. | A novel oral prodrug-targeting transporter MCT 1: 5-fluorouracil-dicarboxylate monoester conjugates | |
| Karabulut et al. | Synthesis of novel dimeric compounds containing triazole using click method and their selective antiproliferative and proapoptotic potential via mitochondrial apoptosis signaling | |
| Xia et al. | Honokiol-Chlorambucil co-prodrugs selectively enhance the killing effect through STAT3 binding on lymphocytic leukemia cells in vitro and in vivo | |
| CN118878600A (zh) | 一种克服阿霉素耐药的脂质体前药的制备和应用 | |
| Cui et al. | Enhanced anticancer activity of glutamate prodrugs of all-trans retinoic acid | |
| Chen et al. | Discovery of 3-peptide substituted arenobufagin derivatives as potent antitumor agents with low cardiotoxicity | |
| CN112979541B (zh) | 一种基于n-(3-羟基吡啶-2-羰基)甘氨酸的抗肿瘤药物增敏剂及其应用 | |
| RU2440998C1 (ru) | Производные 4-арилкумаринов и противоопухолевое лекарственное средство на их основе | |
| Zhang et al. | Ocotillol Derivatives Mitigate Retinal Ischemia-Reperfusion Injury by Regulating the Keap1/Nrf2/ARE Signaling Pathway | |
| Li et al. | Synthesis, anticancer activities, antimicrobial activities and bioavailability of berberine-bile acid analogues | |
| HK1207385B (en) | Sterol derivatives and use thereof for treating diseases involving transformed astrocyte cells or for treating malignant haemopathies | |
| Feng et al. | Discovery of novel peptide–dehydroepiandrosterone hybrids inducing endoplasmic reticulum stress with effective in vitro and in vivo anti-melanoma activities | |
| JP2013521328A (ja) | 遺伝子療法のための非ウイルス性媒体としてのデンドリマー | |
| HK1191654B (en) | Sterol derivatives, method for preparing same, pharmaceutical compositions containing same and use thereof for the treatment of multiple glioblastomas | |
| WO2022052823A1 (zh) | 一种小分子偶联物及其用途 | |
| Chinaglia | Design, synthesis and biological evaluation of novel nucleoside and oligonucleotide conjugates of bio-medical interest. | |
| CN112915087A (zh) | 一种基于5-羧基-8-羟基喹啉的抗肿瘤药物增敏剂及其应用 |